As the immune effects of NIR-PIT are currently unknown it is difficult to know whether this will be of benefit to patients, although it is anticipated that it will augment the therapeutic effect because it is known that cytokines such as interferon γ induce the expression of PD-L1 in different types of tumor cells [36–38]. Here, CD274 is linked to neoplasm.